IRLAB Therapeutics AB
Investor
IRLAB Therapeutics AB
Description
clinical-stage biopharma discovering and developing novel treatments for the most troublesome symptoms of Parkinson's
IRLAB Therapeutics AB
Address
Arvid Wallgrens Backe 20, Göteborg 41347
Gothenburg, Sweden
Gothenburg, Sweden
Contact
info@irlab.se
Description
clinical-stage biopharma discovering and developing novel treatments for the most troublesome symptoms of Parkinson's
Matchmaking
Connect with IRLAB Therapeutics AB
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways